Experiment 569599
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Organism | Crateva religiosa (CAPPARIDACEAE) |
| Citation | SINGH,RG: USHA: KAPOOR,S:. (1991). EVALUATION OF ANTILITHIC PROPERTIES OF VARUN (CRATAEVA NURVALA): AN INDIGENOUS DRUG.. 10(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | STUDY WAS PLANNED TO RECORD THE ANTILITHIC EFFECT OF C.NURVALA IN PTS. OF CAL. OXALATE AND CALCIUM PHOSPHATE NEPHROLITBIASIS. IT INCLUDED 55 AND 15 PROVED PATIENTS OF CALCIUM OXALATE (GROUP-A) AND CAL. PHOSPHATE STONES (GROUP-B) AND 20 AGE/SEX MATCHED CONTROL IN A SPAN OF 3.5 YEARS. THEY WERE TREATED WITH THE VARUN (C.NURVALA) IN THE DOSE OF 350 MG/KG OF BODY WEIGHT PER DAY FOR A PERIOD OF 12 WEEKS IN THE FORM OF FRESHLY PREPARED DECOCTION. THEY WERE FOLLOWED FOR A FURTHER PERIOD OF 6 MONTHS. THE MALE FEMALE RATIO IN THE TWO GROUPS WERE C9.C9: 10.90 AND 4: 1 IN CALCIUM OXALATE AND CALCIUM PHOSPHATE GROUPS RESPECTIVELY WITH PREDOMINACE OF HINDUS. SYMPTOMATIC RELIEF IN TERMS OF PAIN, DYSURIA AND DISAPPEARANCE OF URINARY CRYSTAL WERE NOTICED IN 70.90% AND 63.63% IN GROUP A AND 73.33 AND 53.84% IN GROUP B RESPECTIVELY AT THE END OF THE TREATMENT. RADIOLOGICAL REDUCTION IN SIZE WAS NOTICED IN 33.33% AND 35.71% OF CASES IN GROUP A AND GROUP B RESPECTIVELY. |
| Dose amount | 350.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | KG |
| Dose expression | DOSE |
| Extract | DECOCTION |
| Gender | GIVEN TO BOTH SEXES |